Oxidative stress and paraoxonase 1 activity predict contrast-induced nephropathy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention

Angiology

Volumn 66, Issue 4, 2015, Pages 339-345

  Borekccedili, Abdurrezzak ^a   Gür, Mustafa ^a   Türkoglu, Caner ^b   Çayll, Murat ^c   Selek, Şahbettin ^d   Kaypakll, Onur ^c   Uçar, Hakan ^c   Coşkun, Mehmet ^c   Şeker, Taner ^c   Koç, Mevlüt ^c   Gökdeniz, Teyyar ^a   Gözükara, Mehmet Yavuz ^e  

^a KAFKAS UNIVERSITY   (Turkey)

^b Yenimahalle State Hospital   (Turkey)

^c Adana Numune Training and Research Hospital   (Turkey)

^d HARRAN UNIVERSITY   (Turkey)

^e MERSIN STATE HOSPITAL   (Turkey)

Author keywords

contrast; infarction; nephropathy; oxidative stress; paraoxonase

Indexed keywords

ANTIOXIDANT; ARYLDIALKYLPHOSPHATASE 1; CREATINE KINASE MB; CREATININE; GLUCOSE; IODINATED CONTRAST MEDIUM; IOMEPROL; LOW DENSITY LIPOPROTEIN; MONOCLONAL ANTIBODY; OXIDIZING AGENT; REACTIVE OXYGEN METABOLITE; URIC ACID; ARYLDIALKYLPHOSPHATASE; BIOLOGICAL MARKER; CONTRAST MEDIUM; PON1 PROTEIN, HUMAN;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD SAMPLING; CLINICAL ASSESSMENT; COMPARATIVE STUDY; CONTRAST INDUCED NEPHROPATHY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; ENZYME ACTIVITY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OXIDATIVE STRESS; PATHOGENESIS; PERCUTANEOUS CORONARY INTERVENTION; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TIME TO TREATMENT; ADVERSE EFFECTS; AGED; ANGIOCARDIOGRAPHY; ANTERIOR WALL MYOCARDIAL INFARCTION; BLOOD; CHEMICALLY INDUCED; CHI SQUARE DISTRIBUTION; DIAGNOSTIC USE; ENZYMOLOGY; KIDNEY DISEASES; MULTIVARIATE ANALYSIS; RADIOGRAPHY; RISK FACTOR; STATISTICAL MODEL; TREATMENT OUTCOME;

ADULT; AGED; ANTERIOR WALL MYOCARDIAL INFARCTION; ARYLDIALKYLPHOSPHATASE; BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; CONTRAST MEDIA; CORONARY ANGIOGRAPHY; DIABETES COMPLICATIONS; FEMALE; HUMANS; KIDNEY DISEASES; LINEAR MODELS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OXIDATIVE STRESS; PERCUTANEOUS CORONARY INTERVENTION; PROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 84927515849     PISSN: 00033197     EISSN: 19401574     Source Type: Journal    
DOI: 10.1177/0003319714533588     Document Type: Article

References (35)

1. Elbasan Z, S¸ahin DY, Gür M, et al. Contrast-induced nephropathy in patients with ST elevation myocardial infarction treated with primary percutaneous coronary intervention. Angiology. 2014 ; 65 (1). 37-42
2. Rihal CS, Textor SC, Grill DE, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation. 2002 ; 105 (19). 2259-2264
3. Sadeghi HM, Stone GW, Grines CL, et al. Impact of renal insufficiency in patients undergoing primary angioplasty for acute myocardial infarction. Circulation. 2003 ; 108 (22). 2769-2775
4. Marenzi G, Lauri G, Assanelli E, et al. Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. J Am Coll Cardiol. 2004 ; 44 (9). 1780-1785
5. McCullough PA. Contrast-induced acute kidney injury. J Am Coll Cardiol. 2008 ; 51 (15). 1419-1428
6. Heyman SN, Rosen S, Khamaisi M, Idée JM, Rosenberger C. Reactive oxygen species and the pathogenesis of radiocontrast- induced nephropathy. Invest Radiol. 2010 ; 45 (4). 188-195
7. Erel O. A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem. 2004 ; 37 (4). 277-285
8. Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem. 2005 ; 38 (12). 1103-1111
9. Aviram M, Rosenblat M, Bisgaier CL, et al. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase. J Clin Invest. 1998 ; 101 (8). 1581-1590
10. Akçay AB, Camsarl A, Ozcan T, et al. The relationship between paraoxonase-1 activity and coronary artery disease in patients with metabolic syndrome. Turk Kardiyol Dern Ars. 2011 ; 39 (5). 371-377
11. Killip T, Kimball JT. Treatment of myocardial infarction in a coronary care unit: a two year experience of 250 patients. Am J Cardiol. 1967 ; 20 (4). 457-464
12. Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two dimensional echocardiography. J Am Soc Echocardiogr. 1989 ; 2 (5). 358-367
13. Thomsen HS, Morcos SK. Contrast media and the kidney: European society of urogenital radiology (ESUR) guidelines. Br J Radiol. 2003 ; 76 (908). 513-518
14. Jureti? D, Tadijanovi? M, Reki? B, Simeon-Rudolf V, Reiner E, Barici? M. Serum paraoxonase activities in hemodialyzed uremic patients: cohort study. Croat Med J. 2001 ; 42 (2). 146-150
15. Eckerson HW, Wyte CM, La Du BN. The human serum paraoxonase/arylesterase polymorphism. AmJ Hum Genet. 1983 ; 35: 1126-1138
16. Uçar H, Gür M, Yildirim A, et al. Increased aortic stiffness predicts contrast-induced nephropathy in patients with stable coronary artery disease undergoing percutaneous coronary intervention. Angiology. 2014 ; 65 (9). 806-811
17. Tumlin J, Stacul F, Adam A, et al. Pathophysiology of contrast-induced nephropathy. Am J Cardiol. 2006 ; 98 (6A). 14K - 20K
18. Précourt LP, Amre D, Denis MC, et al. The three-gene paraoxonase family: physiologic roles, actions and regulation. Atherosclerosis. 2011 ; 214 (1). 20-36
19. Fearon IM, Faux SP. Oxidative stress and cardiovascular disease: novel tools give (free) radical insight. J Mol Cell Cardiol. 2009 ; 47 (3). 372-381
20. Persson PB, Tepel M. Contrast medium-induced nephropathy: the pathophysiology. Kidney Int. 2006 ; 69: S8 - S10
21. Hardiek K, Katholi RE, Ramkumar V, Deitrick C. Proximal tubule cell response to radiographic contrast media. Am J Physiol. 2001 ; 280 (1). 61-70
22. Wong GT, Irwin MG. Contrast-induced nephropathy. Br J Anaesth. 2007 ; 99 (4). 474-483
23. Becker LB. New concepts in reactive oxygen species and cardiovascular reperfusion physiology. Cardiovasc Res. 2004 ; 61 (3). 461-470
24. Ueda J, Nygren A, Hansell P, Ulfendahl HR. Effect of intravenous contrast media on proximal and distal tubular hydrostatic pressure in the rat kidney. Acta Radiologica. 1993 ; 34 (1). 83-87
25. Hizoh I, Haller C. Radiocontrast-induced renal tubular cell apoptosis: hypertonic versus oxidative stress. Invest Radiol. 2002 ; 37 (8). 428-434
26. Sandhu C, Newman DJ, Morgan R, Belli AM, Oliveira D. The role of oxygen free radicals in contrast induced nephrotoxicity. Acad Radiol. 2002 ; 9: S436 - S437
27. Fiaccadori E, Maggiore U, Rotelli C, et al. Plasma and urinary free 3-nitrotyrosine following cardiac angiography procedures with nonionic radiocontrast media. Nephrol Dial Transplant. 2004 ; 19 (4). 865-869
28. Duong MH, MacKenzie TA, Malenka DJ. N-acetylcysteine prophylaxis significantly reduces the risk of radiocontrast-induced nephropathy: comprehensive meta-analysis. Catheter Cardiovasc Interv. 2005 ; 64 (4). 471-479
29. Nallamothu BK, Shojania KG, Saint S, et al. Is acetylcysteine effective in preventing contrast-related nephropathy? A meta-analysis. Am J Med. 2004 ; 117 (12). 938-947
30. Spargias K, Alexopoulos E, Kyrzopoulos S, et al. Ascorbic acid prevents contrast-mediated nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention. Circulation. 2004 ; 110 (18). 2837-2842
31. Sadat U, Usman A, Gillard JH, Boyle JR. Does ascorbic acid protect against contrast-induced acute kidney injury in patients undergoing coronary angiography: a systematic review with meta-analysis of randomized, controlled trials. J Am Coll Cardiol. 2013 ; 62 (23). 2167-2175
32. Tasanarong A, Vohakiat A, Hutayanon P, Piyayotai D. New strategy of ?- and ?-tocopherol to prevent contrast-induced acute kidney injury in chronic kidney disease patients undergoing elective coronary procedures. Nephrol Dial Transplant. 2013 ; 28 (2). 337-344
33. Farmer JA. Pleiotropic effects of statins. Curr Atheroscler Rep. 2000 ; 2 (3). 208-217
34. Mikhailidis DP, Athyros VG. Acute kidney injury: Short-term statin therapy for prevention of contrast-induced AKI. Nat Rev Nephrol. 2014 ; 10 (1). 8-9
35. Shah PK. Apolipoprotein A-I/HDL infusion therapy for plaque stabilization-regression: a novel therapeutic approach. Curr Pharm Des. 2007 ; 13 (10). 1031-1038